DICERNA PHARMACEUTICALS INC has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan DICERNA PHARMACEUTICALS INC 401 K PROFIT SHARING PLAN TRUST
401k plan membership statisitcs for DICERNA PHARMACEUTICALS INC 401 K PROFIT SHARING PLAN TRUST
Measure | Date | Value |
---|
2022 : DICERNA PHARMACEUTICALS INC 401 K PROFIT SHARING PLAN TRUST 2022 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2022-06-30 | $0 |
Total transfer of assets to this plan | 2022-06-30 | $0 |
Total transfer of assets from this plan | 2022-06-30 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-06-30 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-06-30 | $0 |
Total income from all sources (including contributions) | 2022-06-30 | $-3,223,580 |
Total loss/gain on sale of assets | 2022-06-30 | $0 |
Total of all expenses incurred | 2022-06-30 | $26,726,024 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-06-30 | $26,680,457 |
Value of total corrective distributions | 2022-06-30 | $23,888 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-06-30 | $326,423 |
Value of total assets at end of year | 2022-06-30 | $0 |
Value of total assets at beginning of year | 2022-06-30 | $29,949,604 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-06-30 | $21,679 |
Total interest from all sources | 2022-06-30 | $80 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-06-30 | $37,986 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-06-30 | Yes |
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan | 2022-06-30 | $0 |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-06-30 | $37,986 |
Was this plan covered by a fidelity bond | 2022-06-30 | Yes |
Value of fidelity bond cover | 2022-06-30 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-06-30 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-06-30 | No |
Participant contributions at beginning of year | 2022-06-30 | $74,404 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-06-30 | $120,440 |
Administrative expenses (other) incurred | 2022-06-30 | $21,679 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-06-30 | No |
Value of net income/loss | 2022-06-30 | $-29,949,604 |
Value of net assets at end of year (total assets less liabilities) | 2022-06-30 | $0 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-06-30 | $29,949,604 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-06-30 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-06-30 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-06-30 | No |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-06-30 | $29,875,200 |
Interest on participant loans | 2022-06-30 | $80 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-06-30 | $-3,588,069 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-06-30 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-06-30 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-06-30 | No |
Contributions received in cash from employer | 2022-06-30 | $205,983 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-06-30 | $26,680,457 |
Did the plan have assets held for investment | 2022-06-30 | No |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-06-30 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-06-30 | Yes |
Opinion of an independent qualified public accountant for this plan | 2022-06-30 | Unqualified |
Accountancy firm name | 2022-06-30 | CARON & BLETZER PLLC |
Accountancy firm EIN | 2022-06-30 | 043499945 |
2021 : DICERNA PHARMACEUTICALS INC 401 K PROFIT SHARING PLAN TRUST 2021 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total transfer of assets to this plan | 2021-12-31 | $0 |
Total transfer of assets from this plan | 2021-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $13,080,053 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $2,096,714 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $2,093,027 |
Value of total corrective distributions | 2021-12-31 | $919 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $9,561,586 |
Value of total assets at end of year | 2021-12-31 | $29,949,604 |
Value of total assets at beginning of year | 2021-12-31 | $18,966,265 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $2,768 |
Total interest from all sources | 2021-12-31 | $2,035 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $1,204,938 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $1,204,938 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $4,869,506 |
Participant contributions at end of year | 2021-12-31 | $74,404 |
Participant contributions at beginning of year | 2021-12-31 | $27,674 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $1,276,361 |
Other income not declared elsewhere | 2021-12-31 | $1,435 |
Administrative expenses (other) incurred | 2021-12-31 | $2,768 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $10,983,339 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $29,949,604 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $18,966,265 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $29,875,200 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $18,938,591 |
Interest on participant loans | 2021-12-31 | $2,035 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $2,310,059 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $3,415,719 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $2,093,027 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | CARON & BLETZER PLLC |
Accountancy firm EIN | 2021-12-31 | 043499945 |
2020 : DICERNA PHARMACEUTICALS INC 401 K PROFIT SHARING PLAN TRUST 2020 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total transfer of assets to this plan | 2020-12-31 | $0 |
Total transfer of assets from this plan | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $9,532,088 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $391,875 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $389,702 |
Value of total corrective distributions | 2020-12-31 | $813 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $6,742,702 |
Value of total assets at end of year | 2020-12-31 | $18,966,265 |
Value of total assets at beginning of year | 2020-12-31 | $9,826,052 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $1,360 |
Total interest from all sources | 2020-12-31 | $1,443 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $447,026 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $447,026 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $3,095,422 |
Participant contributions at end of year | 2020-12-31 | $27,674 |
Participant contributions at beginning of year | 2020-12-31 | $34,610 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $1,415,470 |
Administrative expenses (other) incurred | 2020-12-31 | $1,360 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $9,140,213 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $18,966,265 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $9,826,052 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $18,938,591 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $9,791,442 |
Interest on participant loans | 2020-12-31 | $1,443 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $2,340,917 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $2,231,810 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $389,702 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Unqualified |
Accountancy firm name | 2020-12-31 | CARON & BLETZER, PLLC |
Accountancy firm EIN | 2020-12-31 | 043499945 |